http://dspace.bsu.edu.ru/handle/123456789/46589| Title: | Treatment of hepatitis induced by anti-tuberculosis drugs (experimental research) |
| Authors: | Fedorov, V. N. Smirnov, N. A. Vdovichenko, V. P. Fedorova, T. B. Kerbenev, E. E. |
| Keywords: | medicine pharmacology tuberculosis hepatoprotection hepatoprotector drug-induced liver lesions chorionic gonadotropin luteinizing hormone of hypophysis semax selank |
| Issue Date: | 2020 |
| Citation: | Treatment of hepatitis induced by anti-tuberculosis drugs (experimental research) / V.N. Fedorov [et al.] // Research Results in Pharmacology. - 2020. - Vol.6, №3.-P. 33-39. - Doi: 10.3897/rrpharmacology.6.56453. |
| Abstract: | Tuberculosis is a widely spread infection. While treating patients for it, they are given simultaneously and for a long period 5-6 antibacterial drugs, which are, as a rule, bad for the liver. It quite often (up to 20%) causes drug-induced hepatitis. As experimental means of protecting the liver, the following peptides are suggested: chorionic gonadotropin, a recombinant drug of luteinizing hormone - luveris, and oligopeptide drugs: semax and selank |
| URI: | http://dspace.bsu.edu.ru/handle/123456789/46589 |
| Appears in Collections: | Vol. 6, № 3 |
| File | Description | Size | Format | |
|---|---|---|---|---|
| Fedorov_Treatment.pdf | 366.15 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.